Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer

Fig. 5

S100P + TFF1 + tumor cells correlated with worse EGFR-TKI therapy and immunotherapy response. A Distribution of cells in non-responders (NR) and responders (R) receiving EGFR-TKI therapy. B Distribution of S100P and TFF1 in NR and R receiving EGFR-TKI therapy. C S100P and TFF1 measured by enzyme-linked immunosorbent assay (ELISA) kit showed the most significant upregulation in NR compared to R. D TFF1 showed a significant adverse association with worse clinical outcomes in EGFR-TKI-treated patients. E Distribution of S100P and TFF1 in NR and R receiving immunotherapy. F Role of S100P and TFF1 in predicting the therapeutic results of immunotherapy

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us